- Home
- AIRE vs RNXT Comparison
AIRE vs RNXT Comparison
Compare AIRE & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRE
- RNXT
- Stock Information
- Founded
- AIRE 2021
- RNXT 2012
- Country
- AIRE United States
- RNXT United States
- Employees
- AIRE N/A
- RNXT N/A
- Industry
- AIRE
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- AIRE
- RNXT Health Care
- Exchange
- AIRE Nasdaq
- RNXT Nasdaq
- Market Cap
- AIRE 40.7M
- RNXT 44.0M
- IPO Year
- AIRE N/A
- RNXT 2021
- Fundamental
- Price
- AIRE $0.53
- RNXT $1.03
- Analyst Decision
- AIRE Hold
- RNXT Strong Buy
- Analyst Count
- AIRE 1
- RNXT 2
- Target Price
- AIRE N/A
- RNXT $7.50
- AVG Volume (30 Days)
- AIRE 41.6M
- RNXT 552.5K
- Earning Date
- AIRE 11-12-2025
- RNXT 11-13-2025
- Dividend Yield
- AIRE N/A
- RNXT N/A
- EPS Growth
- AIRE N/A
- RNXT N/A
- EPS
- AIRE N/A
- RNXT N/A
- Revenue
- AIRE $3,043,657.00
- RNXT $662,000.00
- Revenue This Year
- AIRE $410.32
- RNXT $2,895.35
- Revenue Next Year
- AIRE $166.28
- RNXT $313.04
- P/E Ratio
- AIRE N/A
- RNXT N/A
- Revenue Growth
- AIRE 2973.28
- RNXT N/A
- 52 Week Low
- AIRE $0.14
- RNXT $0.75
- 52 Week High
- AIRE $4.49
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- AIRE 45.11
- RNXT 41.45
- Support Level
- AIRE $0.50
- RNXT $0.98
- Resistance Level
- AIRE $0.93
- RNXT $1.14
- Average True Range (ATR)
- AIRE 0.18
- RNXT 0.08
- MACD
- AIRE -0.01
- RNXT -0.01
- Stochastic Oscillator
- AIRE 15.46
- RNXT 14.72
About AIRE reAlpha Tech Corp.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.